fbpx
News
February 4, 2014

In the News Today – February 4, 2014

A pharmaceutical lawyer says that the FDA and DOJ could step up enforcement of off-label drug claims that companies make in press releases and media appearances. Main Justice

A newly released report from Advisen found that corporate and securities litigation dropped by 20 percent in 2013. D & O Diary

Podcasts Episode 18: Why Federal Securities Suits Don’t Belong in State Court Securities Litigation Reform Stock data News D&O Diary Looks At 2021 Litigation Trends Securities Litigation Reform News D&O Diary Blog Calls For Congress To Take Up Securities Reforms Proposed In New ILR Briefly Securities Litigation Reform Blog D&O Diary: "Institute for Legal Reform: Congress Should Enact Reforms to Address Cyan" Securities Litigation Reform News In The News-August 16, 2021 Securities Litigation Reform

Cookie Notice

By clicking “I Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

Cookie Notice

By clicking “I Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Review Settings